000			01957 a2200553 4500
005			20250518074032.0
264		0	_c20200706
008			202007s 0 0 eng d
022			_a2052-1707
024	7		_a10.1002/prp2.537 _2doi
040			_aNLM _beng _cNLM
100	1		_aDowty, Martin E
245	0	0	_aJanus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition. _h[electronic resource]
260			_bPharmacology research & perspectives _c12 2019
300			_ae00537 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntirheumatic Agents _xpharmacology
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aAzetidines _xpharmacology
650	0	4	_aCell Line
650	0	4	_aCytokines _xmetabolism
650	0	4	_aEnzyme Assays
650	0	4	_aFemale
650	0	4	_aHealthy Volunteers
650	0	4	_aHeterocyclic Compounds, 3-Ring _xpharmacology
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aJanus Kinase 1 _xantagonists & inhibitors
650	0	4	_aJanus Kinase Inhibitors _xpharmacology
650	0	4	_aMale
650	0	4	_aPiperidines _xpharmacology
650	0	4	_aPurines
650	0	4	_aPyrazoles
650	0	4	_aPyridines _xpharmacology
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aPyrroles _xpharmacology
650	0	4	_aReceptors, Cytokine _xantagonists & inhibitors
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTriazoles _xpharmacology
700	1		_aLin, Tsung H
700	1		_aJesson, Michael I
700	1		_aHegen, Martin
700	1		_aMartin, David A
700	1		_aKatkade, Vaibhav
700	1		_aMenon, Sujatha
700	1		_aTelliez, Jean-Baptiste
773	0		_tPharmacology research & perspectives _gvol. 7 _gno. 6 _gp. e00537
856	4	0	_uhttps://doi.org/10.1002/prp2.537 _zAvailable from publisher's website
999			_c30415776 _d30415776